Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Capreomycin (500mg) Injection
Therapeutic Category
Antibacterials, Respiratory
Dosage Form
Injection
Packaging Type
Vial
Packaging
500mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Capofen 500 Injection containing Capreomycin is used for the management of resistant tuberculosis infections. It helps inhibit bacterial growth and supports effective anti-tubercular treatment.
Capreomycin works as an anti-tubercular antibiotic that interferes with bacterial protein synthesis, thereby helping control Mycobacterium tuberculosis growth.
The injection is widely used in specialized infectious disease and hospital settings for multidrug-resistant tuberculosis management, leading to consistent institutional demand.
With increasing focus on advanced tuberculosis management and resistant infection control, this product offers strong business potential for retailers and distributors. Its established anti-tubercular action, critical therapeutic relevance, and steady market demand make it a reliable product for growth in the infectious disease care segment.
Some patients may experience injection site pain, dizziness, nausea, kidney function disturbances, hearing impairment, or electrolyte imbalance. Rarely, severe allergic reactions or significant ototoxicity and nephrotoxicity may occur and require immediate medical attention.
Capofen 500 Injection is indicated for multidrug-resistant tuberculosis (MDR-TB) and other resistant mycobacterial infections as part of combination antitubercular therapy. It helps reduce bacterial load and supports long-term infection control.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Regular monitoring of kidney function, hearing, and electrolyte levels is recommended during treatment. Use only as part of an appropriate combination antitubercular regimen.
Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.
Composition : Cefepime (1000mg) Injection
Composition : Cefepime (1000mg) + Tazobactum (125mg)
Composition : Cefepime (250mg)
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Cefoperazone (500mg) + Sulbactam (500mg)
Composition : Ceftazidime (1gm)
Composition : Ceftazidime (250mg)
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Capreomycin 500mg Injection has specialized and high-value demand in the hospital, pulmonology, and infectious disease (TB treatment) segment, making it a niche product for distributors, wholesalers, and pharma franchise partners focused on critical anti-tubercular therapy portfolios.
Distributors and agencies can benefit from hospital-based demand for resistant tuberculosis cases under strict medical supervision. Capreomycin is a second-line injectable anti-tubercular antibiotic Commonly used in multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) cases Used in specialized TB treatment regimens under government and hospital protocols Requires careful monitoring due to its potent action and possible side effects Administered in pulmonology departments and TB specialty centers This strengthens a specialized anti-tubercular and infectious disease hospital portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Capreomycin Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from institutional demand, government and hospital procurement, niche specialty usage, and low competition, along with reliable supply chain support and strong margin potential in the anti-TB segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for specialized infectious disease business growth.